Description
Zenrelia is the NEW treatment for canine allergic itch and inflammation that provides fast and effective relief with just once-daily dosing from the very start.
Zenrelia is indicated for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
Zenrelia is a Janus Kinase (JAK) inhibitor designed to disrupt cytokine signaling pathways that trigger itch and inflammation related to canine allergic and atopic dermatitis2.
Works fast
Visible improvements in allergic itch from day one²
Optimized dosing
No loading or tapering, just once a day from the start
Minimizes opportunity for rebound of itch
Continuous efficacy
Continues to relieve itch and inflammation over the long term
Reduces lesions and inflammation, improving skin condition
In a Head to Head clinical trial, 77% of Zenrelia-treated dogs achieved clinical remission from pruritus compared to 53% of Apoquel-treated dogs